Avectas

Avectas

Avectas

Engineering Cells Fit for Immunotherapy Cell Engineering Gene Editing Cell Therapy CART
Type
B2c
Founded
2012
Raised
$20M
Follow us
Alexa global traffic share
Latest funding
$20,000,000
Venture capital (Series C) - 2020
Seamus Mulligan
Team Size
1–10
Employees
Location
Headquarters
$20,000,000 Venture capital (Series C)
FinSMEs

Avectas Raises $20M in Series C Funding

FinSMEs

Avectas Raises $10M in Equity Funding